Ghrelin is a neuropeptide that has various physiological functions and has been demonstrated to be neuroprotective in a number of neurological disease models. However, the underlying mechanisms of ghrelin in Parkinson's disease remain largely unexplored. The current study aimed to study the effects of ghrelin in a 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease model and evaluate the potential underlying mechanisms. In the present study, we treated an SH-SY5Y cell model with 6-OHDA, and observed that pretreatment with different concentrations of ghrelin (1, 10, and 100 nM) for 30 minutes relieved the neurotoxic effects of 6-OHDA, as revealed by Cell Counting Kit-8 and Annexin V/propidium iodide (PI) apoptosis assays. Reverse transcription quantitative polymerase chain reaction and western blot assay results demonstrated that 6-OHDA treatment upregulated α-synuclein and lincRNA-p21 and downregulated TG-interacting factor 1 (TGIF1), which was predicted as a potential transcription regulator of the gene encoding α-synuclein (SNCA). Ghrelin pretreatment was able to reverse the trends caused by 6-OHDA. The Annexin V/PI apoptosis assay results revealed that inhibiting either α-synuclein or lincRNA-p21 expression with small interfering RNA (siRNA) relieved 6-OHDA-induced cell apoptosis. Furthermore, inhibiting lincRNA-p21 also partially upregulated TGIF1. By retrieving information from a bioinformatics database and performing both double luciferase and RNA immunoprecipitation assays, we found that lincRNA-p21 and TGIF1 were able to form a double-stranded RNA-binding protein Staufen homolog 1 (STAU1) binding site and further activate the STAU1-mediated mRNA decay pathway. In addition, TGIF1 was able to transcriptionally regulate α-synuclein expression by binding to the promoter of SNCA. The Annexin V/PI apoptosis assay results showed that either knockdown of TGIF1 or overexpression of lincRNA-p21 notably abolished the neuroprotective effects of ghrelin against 6-OHDA-induced neurotoxicity. Collectively, these findings suggest that ghrelin exerts neuroprotective effects against 6-OHDA-induced neurotoxicity via the lincRNA-p21/TGIF1/α-synuclein pathway.

Xin He

Department of Neurobiology,School of Life Sciences,China Medical University,Shenyang,Liaoning Province,China;Department of Neurology,Shengjing Hospital of China Medical University,Shenyang,Liaoning Province,China;Department of Orthopedics,First Hospital of China Medical University,Shenyang,Liaoning Province,China;Department of Neurosurgery,Shengjing Hospital of China Medical University,Shenyang,Liaoning Province,China

中国神经再生研究（英文版）

[1]Xin He-.Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells)[J].中国神经再生研究（英文版）,2022(01):170-177

Staufen,STAU1

Ghrelin,alleviates,hydroxydopamine,induced,neurotoxicity,SH,SY5Y,cells,neuropeptide,that,has,various,physiological,functions,been,demonstrated,neuroprotective,number,neurological,disease,models,However,underlying,mechanisms,ghrelin,Parkinson,remain,largely,unexplored,current,study,aimed,effects,OHDA,evaluate,potential,In,present,treated,observed,pretreatment,different,concentrations,nM,minutes,relieved,revealed,by,Cell,Counting,Kit,Annexin,propidium,iodide,apoptosis,assays,Reverse,quantitative,polymerase,chain,reaction,western,blot,results,upregulated,synuclein,lincRNA,p21,downregulated,interacting,TGIF1,which,was,predicted,regulator,gene,encoding,SNCA,able,reverse,trends,caused,inhibiting,either,small,interfering,siRNA,Furthermore,also,partially,By,retrieving,information,from,bioinformatics,database,performing,both,double,luciferase,immunoprecipitation,found,were,stranded,binding,protein,homolog,site,further,activate,mediated,decay,pathway,addition,transcriptionally,promoter,showed,knockdown,overexpression,notably,abolished,against,Collectively,these,findings,suggest,exerts

0.459212